ガス交換肺機能検査の世界市場

ガス交換肺機能検査の世界市場は2030年までに3億1,940万米ドルに達する見込み

2024年に2億4,480万米ドルと推定されるガス交換肺機能検査の世界市場は、2024年から2030年にかけてCAGR 4.5%で成長し、2030年には3億1,940万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるポータブルシステムは、CAGR 5.4％を記録し、分析期間終了時には2億870万米ドルに達すると予測されます。据置型システムセグメントの成長率は、分析期間中CAGR 3.0％と推定されます。

米国市場は6,670万米ドルと推定、中国はCAGR 8.4％で成長予測

米国のガス交換肺機能検査市場は、2024年に6,670万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 8.4%で推移し、2030年には6,680万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8％と3.6％と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界のガス交換肺機能検査市場- 主要動向と促進要因のまとめ

呼吸器健康管理においてガス交換肺機能検査が重要な理由とは？

ガス交換肺機能検査（PFT）は肺機能を評価する上で重要な役割を果たし、肺と血流の間で酸素と二酸化炭素がどれだけ効率よく移動するかを測定します。これらの検査は、慢性閉塞性肺疾患（COPD）、喘息、肺線維症、間質性肺疾患などの呼吸器疾患の診断と管理に不可欠です。最も一般的なガス交換検査には、肺の一酸化炭素拡散能（DLCO）と動脈血ガス（ABG）分析があり、肺の健康と酸素化効率に関する重要な洞察を提供します。これらの検査は、医師が疾患の重症度を判定し、疾患の進行を監視し、治療計画の有効性を評価するのに役立ちます。

大気汚染、喫煙、職業上の危険、COVID-19の長期的影響などの要因による呼吸器疾患の有病率の増加は、肺機能検査の需要を増幅させています。病院、診療所、診断研究所は、疾患の早期発見と個別化治療戦略を改善するため、高度なガス交換検査機器に投資しています。さらに、携帯型PFT装置や非侵襲的モニタリングツールなどの技術的進歩により、特に遠隔地や十分なサービスを受けていない地域における肺機能評価へのアクセスが拡大しています。世界の呼吸器健康への懸念が高まる中、ガス交換肺機能検査は呼吸器ケアと疾病予防の要であり続けます。

肺機能検査技術の主な発展とは？

肺機能検査の分野では、精度、効率、患者の快適性を向上させる技術的進歩が著しいです。最もインパクトのある技術革新の1つは、デジタルスパイロメトリーおよび脈波検査システムの開発であり、より高い精度でリアルタイムの肺機能データを提供します。これらのシステムは、肺機能のパターンを特定するためのAI主導の分析を統合しており、疾患の早期診断や個別化治療の推奨に役立っています。さらに、ウェアラブル呼吸モニタリング機器の採用により、慢性呼吸器疾患患者の肺機能の継続的な追跡が可能になりました。

非侵襲的でポータブルなガス交換検査ソリューションも肺診断学に変革をもたらし、ヘルスケアプロバイダーは従来の病院環境以外でも検査を実施できるようになっています。在宅PFT装置は慢性肺疾患患者の間で人気を集めており、利便性とヘルスケア専門家とのリアルタイムのデータ共有を提供しています。遠隔医療と肺機能検査の統合により、遠隔での患者管理がさらに強化され、医師が直接訪問することなく肺の健康状態をモニターできるようになりました。ヘルスケアシステムがデジタルトランスフォーメーションを受け入れ続ける中、肺機能検査技術の進化は、疾患の早期発見と患者の転帰を改善すると期待されています。

ガス交換肺機能検査市場の拡大を促進する要因は？

ガス交換肺機能検査市場の成長は、呼吸器疾患の負担増、診断技術の進歩、ヘルスケア支出の増加など、いくつかの要因によってもたらされます。COPD、喘息、肺線維症の世界の有病率は、環境汚染物質、喫煙、職業上の危険のために急増しており、広範な肺機能評価が必要となっています。高齢者は呼吸器疾患に罹患しやすいため、定期的な肺機能検査の需要が高まっています。

デジタルヘルスソリューションとAIを活用した診断の採用も市場成長を加速しており、ヘルスケアプロバイダーは疾患の早期発見と治療の最適化のためにスマート呼吸器モニタリングツールを活用しています。さらに、肺の健康に対する認識と検診プログラムを推進する政府の取り組みにより、肺機能検査へのアクセスが拡大しています。遠隔医療サービスと携帯型診断装置の統合が進むことで、特に農村部や十分なサービスを受けていない地域での遠隔肺機能モニタリングがさらに促進されています。技術の進歩が呼吸器診断の形を変え続けているため、ガス交換肺機能検査市場は、技術革新、医療ニーズの高まり、正確でリアルタイムの肺機能評価に対する需要に牽引され、持続的な成長が見込まれています。

セグメント

システムタイプ（ポータブルシステム、据置型システム）、検査方法（ガス拡散試験、心肺運動負荷試験）、用途（慢性閉塞性肺疾患用途、喘息用途、慢性息切れ用途、肺線維症用途、その他用途）、最終用途（病院・クリニック最終用途、診断センター最終用途、その他最終用途）

調査対象企業の例

• 4DMedical
• CHEST M.I., Inc.
• COSMED Srl
• ECO MEDICS AG
• Ganshorn Medizin Electronic
• Hocoma
• KoKo PFT
• Koninklijke Philips N.V.
• Medical Electronic Construction
• Medical Equipment Europe GmbH
• Medical Technologies
• Medipines
• MGC Diagnostics Corporation
• Minato Holdings Inc.
• Morgan Scientific Inc.
• ndd Medizintechnik AG
• NSPIRE HEALTH INC.
• PulmOne Advanced Medical Devices
• Schiller AG
• Vyaire Medical, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Gas Exchange Pulmonary Function Testing Market to Reach US$319.4 Million by 2030

The global market for Gas Exchange Pulmonary Function Testing estimated at US$244.8 Million in the year 2024, is expected to reach US$319.4 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Portable System, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$208.7 Million by the end of the analysis period. Growth in the Stationary System segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$66.7 Million While China is Forecast to Grow at 8.4% CAGR

The Gas Exchange Pulmonary Function Testing market in the U.S. is estimated at US$66.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$66.8 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Gas Exchange Pulmonary Function Testing Market - Key Trends & Drivers Summarized

Why Is Gas Exchange Pulmonary Function Testing Crucial in Respiratory Health Management?

Gas exchange pulmonary function testing (PFT) plays a vital role in assessing lung function, measuring how efficiently oxygen and carbon dioxide are transferred between the lungs and bloodstream. These tests are essential for diagnosing and managing respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and interstitial lung diseases. The most common gas exchange tests include the diffusing capacity of the lungs for carbon monoxide (DLCO) and arterial blood gas (ABG) analysis, which provide crucial insights into lung health and oxygenation efficiency. These tests help physicians determine disease severity, monitor disease progression, and evaluate the effectiveness of treatment plans.

The increasing prevalence of respiratory diseases, driven by factors such as air pollution, smoking, occupational hazards, and the long-term impact of COVID-19, has amplified the demand for pulmonary function testing. Hospitals, clinics, and diagnostic laboratories are investing in advanced gas exchange testing equipment to improve early disease detection and personalized treatment strategies. Furthermore, technological advancements such as portable PFT devices and non-invasive monitoring tools have expanded accessibility to lung function assessments, particularly in remote or underserved regions. As global respiratory health concerns continue to rise, gas exchange pulmonary function testing remains a cornerstone of respiratory care and disease prevention.

What Are the Key Developments in Pulmonary Function Testing Technology?

The field of pulmonary function testing has witnessed significant technological advancements, enhancing accuracy, efficiency, and patient comfort. One of the most impactful innovations is the development of digital spirometry and plethysmography systems, which provide real-time lung function data with greater precision. These systems integrate AI-driven analytics to identify patterns in lung function, aiding in early disease diagnosis and personalized treatment recommendations. Additionally, the adoption of wearable respiratory monitoring devices has enabled continuous tracking of lung function in patients with chronic respiratory conditions.

Non-invasive and portable gas exchange testing solutions are also transforming pulmonary diagnostics, allowing healthcare providers to conduct tests outside traditional hospital settings. Home-based PFT devices are gaining popularity among patients with chronic lung diseases, offering convenience and real-time data sharing with healthcare professionals. The integration of telemedicine with pulmonary function testing has further enhanced remote patient management, enabling physicians to monitor lung health without requiring in-person visits. As healthcare systems continue to embrace digital transformation, the evolution of pulmonary function testing technologies is expected to improve early disease detection and patient outcomes.

Which Factors Are Driving the Expansion of the Gas Exchange Pulmonary Function Testing Market?

The growth in the gas exchange pulmonary function testing market is driven by several factors, including the rising burden of respiratory diseases, advancements in diagnostic technologies, and increased healthcare expenditure. The global prevalence of COPD, asthma, and pulmonary fibrosis has surged due to environmental pollutants, smoking, and occupational hazards, necessitating widespread lung function assessments. The aging population is another significant factor, as elderly individuals are more susceptible to respiratory conditions, driving demand for routine pulmonary function testing.

The adoption of digital health solutions and AI-powered diagnostics is also accelerating market growth, with healthcare providers leveraging smart respiratory monitoring tools for early disease detection and treatment optimization. Additionally, government initiatives promoting lung health awareness and screening programs have expanded the accessibility of pulmonary function tests. The increasing integration of telehealth services and portable diagnostic devices has further facilitated remote lung function monitoring, particularly in rural and underserved regions. As technological advancements continue to reshape respiratory diagnostics, the gas exchange pulmonary function testing market is expected to witness sustained growth, driven by innovation, rising healthcare needs, and the demand for precise, real-time lung function assessments.

SCOPE OF STUDY:

The report analyzes the Gas Exchange Pulmonary Function Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

System Type (Portable System, Stationary System); Test Method (Gas Diffusion Tests, Cardiopulmonary Exercise Testing); Application (Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• 4DMedical
• CHEST M.I., Inc.
• COSMED Srl
• ECO MEDICS AG
• Ganshorn Medizin Electronic
• Hocoma
• KoKo PFT
• Koninklijke Philips N.V.
• Medical Electronic Construction
• Medical Equipment Europe GmbH
• Medical Technologies
• Medipines
• MGC Diagnostics Corporation
• Minato Holdings Inc.
• Morgan Scientific Inc.
• ndd Medizintechnik AG
• NSPIRE HEALTH INC.
• PulmOne Advanced Medical Devices
• Schiller AG
• Vyaire Medical, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Gas Exchange Pulmonary Function Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Prevalence of Respiratory Diseases Spurs Demand for Gas Exchange Pulmonary Function Tests
  • Increasing Adoption of Preventive Healthcare and Early Diagnosis Drives Pulmonary Testing Volumes
  • Growth in Geriatric Population Strengthens Long-Term Demand for Lung Function Monitoring Tools
  • Expansion of Respiratory Care Facilities and Pulmonology Clinics Fuels Equipment Procurement
  • Technological Advancements in Sensor Precision and Software Analytics Enhance Test Accuracy and Adoption
  • Wider Availability of Portable and Point-of-Care Testing Devices Expands Access to Lung Function Assessment
  • Increased Use of Gas Exchange Metrics in Athletic and Performance Medicine Drives Clinical Applications
  • Integration with Electronic Medical Records (EMR) Systems Supports Streamlined Clinical Workflows
  • Demand for Real-Time Testing in Critical Care Units Drives Innovation in Bedside Pulmonary Function Tools
  • Increased R&D Investment in Non-Invasive Respiratory Diagnostics Spurs Device Miniaturization
  • Adoption of Telehealth and Remote Monitoring Expands Reach of Home-Based Pulmonary Function Testing
  • Growing Awareness of Occupational Lung Disorders Spurs Routine Screening in Industrial Settings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Gas Exchange Pulmonary Function Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Portable System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Portable System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Portable System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Stationary System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Stationary System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Stationary System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Gas Diffusion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Gas Diffusion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Gas Diffusion Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiopulmonary Exercise Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiopulmonary Exercise Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cardiopulmonary Exercise Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Chronic Shortness of Breath Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Chronic Shortness of Breath Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Chronic Shortness of Breath Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pulmonary Fibrosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pulmonary Fibrosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pulmonary Fibrosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION